$1,318.00
This Market Spotlight report covers the Fragile X Syndrome market, comprising key pipeline drugs, clinical trials, recent events and analyst opinion, probability of success, a discussion on disease epidemiology, and licensing and asset acquisition deals.
This Market Spotlight report covers the Fragile X Syndrome market, comprising key pipeline drugs, clinical trials, recent events and analyst opinion, key upcoming events, probability of success, a discussion on disease epidemiology, and licensing and asset acquisition deals.
Key Takeaways
CONTENTS
5 OVERVIEW
6 KEY TAKEAWAYS
7 DISEASE BACKGROUND
8 TREATMENT
9 EPIDEMIOLOGY
9 Premutation
10 PIPELINE DRUGS
14 RECENT EVENTS AND ANALYST OPINION
14 BPN14770 for FXS (November 2, 2020)
15 Zygel for FXS (October 15, 2020)
18 KEY UPCOMING EVENTS
19 PROBABILITY OF SUCCESS
20 LICENSING AND ASSET ACQUISITION DEALS
20 Lysogene Gets SATT Conectus’s Fragile X Gene Therapy Candidate
21 CLINICAL TRIAL LANDSCAPE
22 Sponsors by status
23 Sponsors by phase
25 BIBLIOGRAPHY
26 APPENDIX
LIST OF FIGURES
10 Figure 1: Overview of pipeline drugs for FXS in the US
10 Figure 2: Pipeline drugs for FXS, by company
11 Figure 3: Pipeline drugs for FXS, by drug type
11 Figure 4: Pipeline drugs for FXS, by classification
15 Figure 5: BPN14770 for FXS (November 2, 2020): Phase II – Adults
17 Figure 6: Zygel for FXS (October 15, 2020): Phase III – CONNECT-FX (US, AUS, NZ)
18 Figure 7: Key upcoming events in FXS
19 Figure 8: Probability of success in the neurodevelopmental disorders pipeline
21 Figure 9: Clinical trials in FXS
21 Figure 10: Top 10 drugs for clinical trials in FXS
22 Figure 11: Top 10 companies for clinical trials in FXS
22 Figure 12: Trial locations in FXS
23 Figure 13: FXS trials status
24 Figure 14: FXS trials sponsors, by phase
LIST OF TABLES
12 Table 1: Pipeline drugs for FXS in the US
14 Table 2: BPN14770 for FXS (November 2, 2020)
16 Table 3: Zygel for FXS (October 15, 2020)
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!